Catalyst Biosciences' Series D - II Round

Catalyst Biosciences raised a round of funding on April 23, 2014.

Catalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform …

Articles about Catalyst Biosciences' Series D - II Round: